Active 0 6 0 6 O
disorders 7 16 7 16 B-chronic_disease
that 17 21 17 21 O
have 22 26 22 26 O
been 27 31 27 31 O
reported 32 40 32 40 O
to 41 43 41 43 O
affect 44 50 44 50 O
tryptophan 51 61 51 61 O
metabolism 62 72 62 72 O
or 73 75 73 75 O
interfere 76 85 76 85 O
with 86 90 86 90 O
absorption 91 101 91 101 O
will 102 106 102 106 O
be 107 109 107 109 O
excluded 110 118 110 118 O
( 119 120 119 120 O
Acute 120 125 120 125 B-chronic_disease
Intermittent 126 138 126 138 I-chronic_disease
Porphyria 139 148 139 148 I-chronic_disease
, 148 149 148 149 O
Celiac 150 156 150 156 B-chronic_disease
Disease 157 164 157 164 I-chronic_disease
, 164 165 164 165 O
Crohn 166 171 166 171 B-chronic_disease
's 171 173 171 173 I-chronic_disease
Disease 174 181 174 181 I-chronic_disease
, 181 182 181 182 O
Irritable 183 192 183 192 B-chronic_disease
Bowel 193 198 193 198 I-chronic_disease
Syndrome 199 207 199 207 I-chronic_disease

Calgary 0 7 208 215 B-clinical_variable
Depression 8 18 216 226 I-clinical_variable
Scale 19 24 227 232 I-clinical_variable
total 25 30 233 238 I-clinical_variable
score 31 36 239 244 I-clinical_variable
≥ 37 38 245 246 O
10 39 41 247 249 B-lower_bound
at 42 44 250 252 O
baseline 45 53 253 261 O

Claustrophobia 0 14 262 276 B-chronic_disease

Current 0 7 277 284 O
smoker 8 14 285 291 O
( 15 16 292 293 O
expired 16 23 293 300 B-clinical_variable
CO 24 26 301 303 I-clinical_variable
≥ 27 28 304 305 O
10 29 31 306 308 B-lower_bound
ppm 32 35 309 312 I-lower_bound
) 35 36 312 313 O

Current 0 7 314 321 O
use 8 11 322 325 O
of 12 14 326 328 O
nicotine 15 23 329 337 B-treatment
replacement 24 35 338 349 I-treatment
therapy 36 43 350 357 I-treatment
or 44 46 358 360 O
other 47 52 361 366 O
nicotine 53 61 367 375 O
products 62 70 376 384 O

DSM 0 3 385 388 O
- 3 4 388 389 O
IV 4 6 389 391 O
- 6 7 391 392 O
TR 7 9 392 394 O
/ 9 10 394 395 O
DSM-5 10 15 395 400 O
substance 16 25 401 410 O
abuse 26 31 411 416 O
in 32 34 417 419 O
the 35 38 420 423 O
last 39 43 424 428 O
month 44 49 429 434 O
or 50 52 435 437 O
substance 53 62 438 447 O
dependence 63 73 448 458 O
in 74 76 459 461 O
the 77 80 462 465 O
last 81 85 466 470 B-upper_bound
6 86 87 471 472 I-upper_bound
months 88 94 473 479 I-upper_bound
( 95 96 480 481 O
documented 96 106 481 491 O
by 107 109 492 494 O
SCID 110 114 495 499 O
) 114 115 499 500 O

Excessive 0 9 501 510 O
self 10 14 511 515 O
- 14 15 515 516 O
reported 15 23 516 524 O
daily 24 29 525 530 O
caffeine 30 38 531 539 B-treatment
intake 39 45 540 546 O
, 45 46 546 547 O
defined 47 54 548 555 O
as 55 57 556 558 O
intake 58 64 559 565 O
exceeding 65 74 566 575 O
1000 75 79 576 580 B-lower_bound
mg 80 82 581 583 I-lower_bound
or 83 85 584 586 O
the 86 89 587 590 O
equivalent 90 100 591 601 O
of 101 103 602 604 O
8 104 105 605 606 O
cups 106 110 607 611 O
of 111 113 612 614 O
coffee 114 120 615 621 O

Has 0 3 622 625 O
met 4 7 626 629 O
DSM 8 11 630 633 O
- 11 12 633 634 O
IV 12 14 634 636 O
- 14 15 636 637 O
TR 15 17 637 639 O
/ 17 18 639 640 O
DSM-5 18 23 640 645 O
Criteria 24 32 646 654 O
for 33 36 655 658 O
schizophrenia 37 50 659 672 B-chronic_disease
, 50 51 672 673 O
schizoaffective 52 67 674 689 B-chronic_disease
disorder 68 76 690 698 I-chronic_disease
or 77 79 699 701 O
schizophreniform 80 96 702 718 B-chronic_disease
disorder 97 105 719 727 I-chronic_disease

History 0 7 728 735 O
of 8 10 736 738 O
an 11 13 739 741 O
organic 14 21 742 749 B-chronic_disease
brain 22 27 750 755 I-chronic_disease
disorder 28 36 756 764 I-chronic_disease
; 36 37 764 765 O
mental 38 44 766 772 B-chronic_disease
retardation 45 56 773 784 I-chronic_disease
; 56 57 784 785 O
or 58 60 786 788 O
a 61 62 789 790 O
medical 63 70 791 798 O
condition 71 80 799 808 O
, 80 81 808 809 O
whose 82 87 810 815 O
pathology 88 97 816 825 O
or 98 100 826 828 O
treatment 101 110 829 838 B-treatment
could 111 116 839 844 O
alter 117 122 845 850 O
cognition 123 132 851 860 O

Males 0 5 861 866 B-gender

Metal 0 5 867 872 O
in 6 8 873 875 O
body 9 13 876 880 O
that 14 18 881 885 O
will 19 23 886 890 O
interfere 24 33 891 900 O
with 34 38 901 905 O
MR 39 41 906 908 B-treatment
imaging 42 49 909 916 I-treatment

No 0 2 917 919 O
DSM 3 6 920 923 O
- 6 7 923 924 O
IV 7 9 924 926 O
- 9 10 926 927 O
TR 10 12 927 929 O
/ 12 13 929 930 O
DSM-5 13 18 930 935 O
Axis 19 23 936 940 B-chronic_disease
I 24 25 941 942 I-chronic_disease
Disorder 26 34 943 951 I-chronic_disease
( 35 36 952 953 O
documented 36 46 953 963 O
by 47 49 964 966 O
SCID 50 54 967 971 O
) 54 55 971 972 O

Post 0 4 973 977 O
- 4 5 977 978 O
menopausal 5 15 978 988 O
women 16 21 989 994 B-gender
will 22 26 995 999 O
not 27 30 1000 1003 O
be 31 33 1004 1006 O
included 34 42 1007 1015 O
due 43 46 1016 1019 O
to 47 49 1020 1022 O
changes 50 57 1023 1030 O
in 58 60 1031 1033 O
the 61 64 1034 1037 O
HPA 65 68 1038 1041 O
axis 69 73 1042 1046 O
expression 74 84 1047 1057 O
and 85 88 1058 1061 O
hormonal 89 97 1062 1070 O
effects 98 105 1071 1078 O
on 106 108 1079 1081 O
cognition 109 118 1082 1091 O
. 118 119 1091 1092 O
In 120 122 1093 1095 O
women 123 128 1096 1101 O
over 129 133 1102 1106 O
the 134 137 1107 1110 O
age 138 141 1111 1114 B-age
of 142 144 1115 1117 O
45 145 147 1118 1120 B-lower_bound
, 147 148 1120 1121 O
menopausal 149 159 1122 1132 O
status 160 166 1133 1139 O
will 167 171 1140 1144 O
be 172 174 1145 1147 O
evaluated 175 184 1148 1157 O
clinically 185 195 1158 1168 O

Pregnancy 0 9 1169 1178 B-pregnancy

Prescription 0 12 1179 1191 O
of 13 15 1192 1194 O
antipsychotic 16 29 1195 1208 B-treatment
medication 30 40 1209 1219 I-treatment
for 41 44 1220 1223 O
at 45 47 1224 1226 O
least 48 53 1227 1232 O
60 54 56 1233 1235 B-lower_bound
days 57 61 1236 1240 I-lower_bound
and 62 65 1241 1244 O
constant 66 74 1245 1253 O
dose 75 79 1254 1258 O
for 80 83 1259 1262 O
30 84 86 1263 1265 B-upper_bound
days 87 91 1266 1270 I-upper_bound
prior 92 97 1271 1276 I-upper_bound
to 98 100 1277 1279 O
study 101 106 1280 1285 O
entry 107 112 1286 1291 O
( 113 114 1292 1293 O
either 114 120 1293 1299 O
first 121 126 1300 1305 O
or 127 129 1306 1308 O
second 130 136 1309 1315 O
generation 137 147 1316 1326 O
antipsychotics 148 162 1327 1341 B-treatment
permitted 163 172 1342 1351 O
) 172 173 1351 1352 O

Treatment 0 9 1353 1362 O
with 10 14 1363 1367 O
monoamine 15 24 1368 1377 B-treatment
oxidase 25 32 1378 1385 I-treatment
inhibitors 33 43 1386 1396 I-treatment
, 43 44 1396 1397 O
migraine 45 53 1398 1406 B-treatment
headache 54 62 1407 1415 I-treatment
medications 63 74 1416 1427 I-treatment
( 75 76 1428 1429 O
triptans 76 84 1429 1437 B-treatment
) 84 85 1437 1438 O
and 86 89 1439 1442 O
dextromethorphan 90 106 1443 1459 B-treatment

Women 0 5 1460 1465 B-gender
must 6 10 1466 1470 O
be 11 13 1471 1473 O
in 14 16 1474 1476 O
the 17 20 1477 1480 O
first 21 26 1481 1486 O
half 27 31 1487 1491 O
of 32 34 1492 1494 O
their 35 40 1495 1500 O
menstrual 41 50 1501 1510 O
cycle 51 56 1511 1516 O
at 57 59 1517 1519 O
the 60 63 1520 1523 O
time 64 68 1524 1528 O
of 69 71 1529 1531 O
the 72 75 1532 1535 O
2 76 77 1536 1537 O
challenge 78 87 1538 1547 O
visits 88 94 1548 1554 O

ages 0 4 1555 1559 B-age
of 5 7 1560 1562 O
18 8 10 1563 1565 B-lower_bound
and 11 14 1566 1569 O
55 15 17 1570 1572 B-upper_bound
years 18 23 1573 1578 I-upper_bound

females 0 7 1579 1586 B-gender

females 0 7 1587 1594 B-gender
between 8 15 1595 1602 O
the 16 19 1603 1606 O
ages 20 24 1607 1611 B-age
of 25 27 1612 1614 O
18 28 30 1615 1617 B-lower_bound
and 31 34 1618 1621 O
55 35 37 1622 1624 B-upper_bound
years 38 43 1625 1630 I-upper_bound

